ES2126331T3 - Conjugados de bdnf y nt-3 con un polimero soluble en agua. - Google Patents
Conjugados de bdnf y nt-3 con un polimero soluble en agua.Info
- Publication number
- ES2126331T3 ES2126331T3 ES95939123T ES95939123T ES2126331T3 ES 2126331 T3 ES2126331 T3 ES 2126331T3 ES 95939123 T ES95939123 T ES 95939123T ES 95939123 T ES95939123 T ES 95939123T ES 2126331 T3 ES2126331 T3 ES 2126331T3
- Authority
- ES
- Spain
- Prior art keywords
- water soluble
- soluble polymer
- bdnf
- conjugates
- polypeptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 title abstract 2
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 title abstract 2
- 229920003169 water-soluble polymer Polymers 0.000 title abstract 2
- -1 FOR EXAMPLE Polymers 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 238000010348 incorporation Methods 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/839—Nerves; brain
Abstract
SE HAN PREPARADO DERIVADOS DE FACTORES NEUROTROFICOS BDNF Y NT3 MEDIANTE INCORPORACION DE ESTOS POLIPEPTIDOS A UN POLIMERO SOLUBLE EN AGUA, POR EJEMPLO, POLIETILENGLICOL.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/340,131 US5770577A (en) | 1994-11-14 | 1994-11-14 | BDNF and NT-3 polypeptides selectively linked to polyethylene glycol |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2126331T3 true ES2126331T3 (es) | 1999-03-16 |
Family
ID=23332020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95939123T Expired - Lifetime ES2126331T3 (es) | 1994-11-14 | 1995-11-13 | Conjugados de bdnf y nt-3 con un polimero soluble en agua. |
Country Status (22)
Country | Link |
---|---|
US (1) | US5770577A (es) |
EP (1) | EP0792288B1 (es) |
JP (1) | JPH10508853A (es) |
KR (1) | KR100253762B1 (es) |
CN (1) | CN1173183A (es) |
AT (1) | ATE175973T1 (es) |
AU (1) | AU694589B2 (es) |
CA (1) | CA2204640C (es) |
CZ (1) | CZ137597A3 (es) |
DE (1) | DE69507507T2 (es) |
DK (1) | DK0792288T3 (es) |
ES (1) | ES2126331T3 (es) |
GR (1) | GR3029790T3 (es) |
HU (1) | HUT77747A (es) |
IL (1) | IL115965A (es) |
MX (1) | MX9703362A (es) |
NO (1) | NO972176L (es) |
NZ (1) | NZ296452A (es) |
RU (1) | RU2136694C1 (es) |
SK (1) | SK283083B6 (es) |
WO (1) | WO1996015146A1 (es) |
ZA (1) | ZA959653B (es) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5824784A (en) * | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
JPH10212241A (ja) * | 1996-05-27 | 1998-08-11 | Sumitomo Pharmaceut Co Ltd | Bdnfを安定に含有する製剤 |
AU720232B2 (en) | 1996-07-19 | 2000-05-25 | Amgen, Inc. | Analogs of cationic proteins |
WO2000024415A2 (en) * | 1998-10-28 | 2000-05-04 | Cornell Research Foundation, Inc. | Methods for regulating angiogenesis and vascular integrity using trk receptor ligands |
US6656474B1 (en) * | 1999-01-15 | 2003-12-02 | Regeneron Pharmaceuticals, Inc. | Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders |
US6800607B2 (en) * | 2000-02-29 | 2004-10-05 | Ltt Bio-Pharma Co., Ltd. | Modified BDNF |
US7514239B2 (en) * | 2000-03-28 | 2009-04-07 | Amgen Inc. | Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof |
US6586398B1 (en) | 2000-04-07 | 2003-07-01 | Amgen, Inc. | Chemically modified novel erythropoietin stimulating protein compositions and methods |
US7442370B2 (en) * | 2001-02-01 | 2008-10-28 | Biogen Idec Ma Inc. | Polymer conjugates of mutated neublastin |
SI1355936T1 (sl) * | 2001-02-01 | 2007-12-31 | Biogen Idec Inc | Polimerni konjugati neublastina in postopki njihove uporabe |
PL362414A1 (en) | 2001-02-19 | 2004-11-02 | Merck Patent Gmbh | Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity |
US7276580B2 (en) * | 2001-03-12 | 2007-10-02 | Biogen Idec Ma Inc. | Neurotrophic factors |
JP4571776B2 (ja) * | 2002-11-05 | 2010-10-27 | Jx日鉱日石エネルギー株式会社 | 潤滑油組成物 |
EA008866B1 (ru) * | 2002-12-26 | 2007-08-31 | Маунтин Вью Фамэсьютикэлс, Инк. | ПОЛИМЕРНЫЙ КОНЪЮГАТ МОДИФИКАЦИЙ ИНТЕРФЕРОНА-β, ФАРМАЦЕВТИЧЕСКИЕ ПРОДУКТЫ НА ЕГО ОСНОВЕ И СПОСОБ ИХ ПОЛУЧЕНИЯ |
PL396711A1 (pl) * | 2002-12-26 | 2011-12-19 | Mountain View Pharmaceuticals, Inc. | Koniugaty polimerów z cytokinami, chemokinami, czynnikami wzrostu, hormonami polipeptydowymi i ich antagonistami, kompozycja farmaceutyczna i sposób zapobiegania, diagnozowania lub leczenia |
NZ541921A (en) * | 2003-01-31 | 2010-01-29 | Biogen Idec Inc | Polymer conjugates of mutated neublastin |
SI2248899T1 (sl) | 2003-03-19 | 2015-07-31 | Biogen Ma Inc. | Vezavni protein receptorja Nogo |
ES2479942T3 (es) | 2003-04-18 | 2014-07-25 | Biogen Idec Ma Inc. | Neublastina glucosilada conjugada con polímero |
EP1720564A1 (en) * | 2004-02-20 | 2006-11-15 | Rinat Neuroscience Corp. | Methods of treating obesity or diabetes using nt-4/5 |
EP2474317A1 (en) | 2004-06-24 | 2012-07-11 | Biogen Idec MA Inc. | Treatment of conditions involving demyelination |
EP2238983B1 (en) * | 2004-08-19 | 2014-07-23 | Biogen Idec MA Inc. | Neublastin variants |
EP1784203B1 (en) | 2004-08-19 | 2010-06-30 | Biogen Idec MA Inc. | Refolding transforming growth factor beta family proteins |
US7750122B2 (en) | 2005-06-06 | 2010-07-06 | Wyeth Llc | Anti-TrkB monoclonal antibodies and uses thereof |
WO2007008547A2 (en) | 2005-07-08 | 2007-01-18 | Biogen Idec Ma Inc. | Sp35 antibodies and uses thereof |
CA2637707A1 (en) * | 2006-02-02 | 2007-08-09 | Rinat Neuroscience Corporation | Methods for treating obesity by administering a trkb antagonist |
AU2007210862A1 (en) * | 2006-02-02 | 2007-08-09 | Rinat Neuroscience Corp. | Methods for treating unwanted weight loss or eating disorders by administering a trkB agonist |
TWI501774B (zh) | 2006-02-27 | 2015-10-01 | Biogen Idec Inc | 神經性病症之治療 |
WO2007103182A2 (en) * | 2006-03-01 | 2007-09-13 | Biogen Idec Ma Inc. | Compostions and methods for administering gdnf ligand family proteins |
AU2007249709A1 (en) * | 2006-05-15 | 2007-11-22 | Viral Logic Systems Technology Corp. | CD47 related compositions and methods for treating immunological diseases and disorders |
US8377448B2 (en) * | 2006-05-15 | 2013-02-19 | The Board Of Trustees Of The Leland Standford Junior University | CD47 related compositions and methods for treating immunological diseases and disorders |
US20100086997A1 (en) * | 2006-12-20 | 2010-04-08 | Rinat Enuroscience Corp | TrkB Agonists for Treating Autoimmune Disorders |
EP2142205B1 (en) | 2007-05-01 | 2014-04-02 | Biogen Idec MA Inc. | Neublastin peptides for use in increasing vascularisation in tissue with impaired blood flow |
EP2205634A2 (en) * | 2007-08-08 | 2010-07-14 | Biogen Idec MA, Inc. | Anti-neublastin antibodies and uses thereof |
US20100297121A1 (en) * | 2007-10-11 | 2010-11-25 | Biogen Idec Ma Inc. | Methods for Treating Pressure Induced Optic Neuropathy, Preventing Neuronal Degeneration and Promoting Neuronal Cell Survival Via Administration of LINGO-1 Antagonists and TrkB Agonists |
CA2702630C (en) * | 2007-11-08 | 2017-11-21 | Biogen Idec Ma Inc. | Use of lingo-4 antagonists in the treatment of conditions involving demyelination |
US8058406B2 (en) | 2008-07-09 | 2011-11-15 | Biogen Idec Ma Inc. | Composition comprising antibodies to LINGO or fragments thereof |
MX2013000250A (es) | 2010-07-02 | 2013-10-28 | Angiochem Inc | Polipeptidos cortos y que contienen d-aminoacido para conjugados terapeuticos y usos de los mismos. |
CA2873623C (en) | 2012-05-14 | 2021-11-09 | Biogen Idec Ma Inc. | Lingo-2 antagonists for treatment of conditions involving motor neurons |
CN102964442B (zh) * | 2012-11-19 | 2015-04-29 | 未名生物医药有限公司 | 一种聚乙二醇同神经生长因子结合物的制备方法 |
MX2017009038A (es) | 2015-01-08 | 2017-10-25 | Biogen Ma Inc | Antagonistas de proteina 1 de interacción con el receptor de nogo que contiene el dominio de inmunoglobulina y repeticiones ricas en leucina (lingo-1) y usos para el tratamiento de trastornos desmielinizantes. |
CN111514279B (zh) * | 2020-06-16 | 2023-07-18 | 温州医科大学附属第二医院(温州医科大学附属育英儿童医院) | 神经营养因子3在制备治疗男性性腺功能减退症的药物中的应用 |
CN115025723A (zh) * | 2022-05-10 | 2022-09-09 | 吉林大学 | 经神经生长因子及多巴胺改良的peg-plga微球 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US4002531A (en) * | 1976-01-22 | 1977-01-11 | Pierce Chemical Company | Modifying enzymes with polyethylene glycol and product produced thereby |
US5169762A (en) * | 1983-03-03 | 1992-12-08 | Genentech, Inc. | Human nerve growth factor by recombinant technology |
DE3572982D1 (en) * | 1984-03-06 | 1989-10-19 | Takeda Chemical Industries Ltd | Chemically modified lymphokine and production thereof |
GB8430252D0 (en) * | 1984-11-30 | 1985-01-09 | Beecham Group Plc | Compounds |
US4904584A (en) * | 1987-12-23 | 1990-02-27 | Genetics Institute, Inc. | Site-specific homogeneous modification of polypeptides |
CA1340810C (en) * | 1988-03-31 | 1999-11-02 | Motoo Yamasaki | Polypeptide derivatives of human granulocyte colony stimulating factor |
EP0401384B1 (en) * | 1988-12-22 | 1996-03-13 | Kirin-Amgen, Inc. | Chemically modified granulocyte colony stimulating factor |
GR1000980B (el) * | 1989-08-30 | 1993-03-31 | Max Planck Gesellschaft | Νευροτροφινη-3,ενας νεος neυροτροφικος παραγοντας που σχετιζεται με τον παραγοντα αναπτυξης νευρων και τον νευροτροφικο παραγοντα που προερχεται απο τον εγκεφαλο. |
US5180820A (en) * | 1989-08-30 | 1993-01-19 | Barde Yves Alain | Brain-derived neurotrophic factor |
US5229500A (en) * | 1989-08-30 | 1993-07-20 | Regeneron Pharmaceuticals, Inc. | Brain derived neurotrophic factor |
US5182107A (en) * | 1989-09-07 | 1993-01-26 | Alkermes, Inc. | Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates |
JPH04218000A (ja) * | 1990-02-13 | 1992-08-07 | Kirin Amgen Inc | 修飾ポリペプチド |
IE912365A1 (en) * | 1990-07-23 | 1992-01-29 | Zeneca Ltd | Continuous release pharmaceutical compositions |
AU654302B2 (en) * | 1990-09-25 | 1994-11-03 | Genentech Inc. | Novel neurothrophic factor |
US5252714A (en) * | 1990-11-28 | 1993-10-12 | The University Of Alabama In Huntsville | Preparation and use of polyethylene glycol propionaldehyde |
US5389529A (en) * | 1991-06-12 | 1995-02-14 | Regeneron Pharmaceuticals, Inc. | Modified lamβ signal sequence and processes for producing recombinant neurotrophins |
NZ244778A (en) * | 1991-10-21 | 1994-03-25 | Ortho Pharma Corp | Peg imidates and protein derivatives thereof |
US5260308A (en) * | 1991-11-06 | 1993-11-09 | Mayo Foundation For Medical Education And Research | Method to increase permeability of the blood-nerve/brain barriers to proteins |
US5468872A (en) * | 1993-09-16 | 1995-11-21 | Cephalon, Inc. | K-252a functional derivatives potentiate neurotrophin-3 for the treatment of neurological disorders |
-
1994
- 1994-11-14 US US08/340,131 patent/US5770577A/en not_active Expired - Lifetime
-
1995
- 1995-11-12 IL IL11596595A patent/IL115965A/en active IP Right Grant
- 1995-11-13 NZ NZ296452A patent/NZ296452A/xx unknown
- 1995-11-13 AT AT95939123T patent/ATE175973T1/de not_active IP Right Cessation
- 1995-11-13 ES ES95939123T patent/ES2126331T3/es not_active Expired - Lifetime
- 1995-11-13 SK SK571-97A patent/SK283083B6/sk unknown
- 1995-11-13 RU RU97107892/04A patent/RU2136694C1/ru not_active IP Right Cessation
- 1995-11-13 CN CN95197321A patent/CN1173183A/zh active Pending
- 1995-11-13 HU HU9800671A patent/HUT77747A/hu unknown
- 1995-11-13 EP EP95939123A patent/EP0792288B1/en not_active Expired - Lifetime
- 1995-11-13 DK DK95939123T patent/DK0792288T3/da active
- 1995-11-13 WO PCT/US1995/014658 patent/WO1996015146A1/en not_active Application Discontinuation
- 1995-11-13 CA CA002204640A patent/CA2204640C/en not_active Expired - Fee Related
- 1995-11-13 KR KR1019970703211A patent/KR100253762B1/ko not_active IP Right Cessation
- 1995-11-13 AU AU41071/96A patent/AU694589B2/en not_active Ceased
- 1995-11-13 DE DE69507507T patent/DE69507507T2/de not_active Expired - Lifetime
- 1995-11-13 JP JP8516219A patent/JPH10508853A/ja not_active Ceased
- 1995-11-13 CZ CZ971375A patent/CZ137597A3/cs unknown
- 1995-11-13 MX MX9703362A patent/MX9703362A/es not_active IP Right Cessation
- 1995-11-14 ZA ZA9509653A patent/ZA959653B/xx unknown
-
1997
- 1997-05-12 NO NO972176A patent/NO972176L/no not_active Application Discontinuation
-
1999
- 1999-03-23 GR GR990400878T patent/GR3029790T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2204640C (en) | 2001-01-09 |
ATE175973T1 (de) | 1999-02-15 |
CZ137597A3 (cs) | 1998-10-14 |
DK0792288T3 (da) | 1999-09-13 |
DE69507507T2 (de) | 1999-05-27 |
NO972176L (no) | 1997-07-14 |
CN1173183A (zh) | 1998-02-11 |
MX9703362A (es) | 1997-08-30 |
SK57197A3 (en) | 1999-02-11 |
NZ296452A (en) | 1999-01-28 |
DE69507507D1 (de) | 1999-03-04 |
AU4107196A (en) | 1996-06-06 |
GR3029790T3 (en) | 1999-06-30 |
HUT77747A (hu) | 1998-07-28 |
SK283083B6 (sk) | 2003-02-04 |
EP0792288B1 (en) | 1999-01-20 |
RU2136694C1 (ru) | 1999-09-10 |
CA2204640A1 (en) | 1996-05-23 |
US5770577A (en) | 1998-06-23 |
AU694589B2 (en) | 1998-07-23 |
IL115965A0 (en) | 1996-01-31 |
IL115965A (en) | 2001-01-28 |
NO972176D0 (no) | 1997-05-12 |
ZA959653B (en) | 1997-08-26 |
KR100253762B1 (ko) | 2000-05-01 |
EP0792288A1 (en) | 1997-09-03 |
JPH10508853A (ja) | 1998-09-02 |
WO1996015146A1 (en) | 1996-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2126331T3 (es) | Conjugados de bdnf y nt-3 con un polimero soluble en agua. | |
FI931278A (fi) | Polymerer, som innehaoller sulfogrupper | |
DE69726229D1 (de) | Prothese mit Flansch | |
FI961253A0 (fi) | Virtsaputkeen tiivistyvä peitetulppa | |
ATE209882T1 (de) | Totale gelenkprothese mit beweglichem lager | |
MY125467A (en) | Olanzapine dihydrate d | |
DE69008954T2 (de) | Einsetzbares künstliches Schliessmuskelsystem. | |
FI940738A (fi) | Elektroneja johtavia molekyylivalmisteita | |
DE68912018D1 (de) | UV-härtbare Polymerzusammensetzung. | |
DE69707275D1 (de) | Dichter elektrochemischer generator mit endschutzschalter | |
BR9503330A (pt) | Recipiente dotado de um colo aberto anular | |
DE69121461D1 (de) | Lichtempfindliches, wärmebeständiges Polymer mit Hydroxyphenylgruppen | |
DE69001409T2 (de) | Wasserquellbare Dichtung. | |
DE3862372D1 (de) | Polyphenylenaether, polyoctenylen und polyethylen enthaltende polymermischung. | |
FR2706285B1 (fr) | Prothèse anti-luxation. | |
AU4435089A (en) | Preparation of poly(aryl ether/thioether)-polyester block copolymers | |
EP0621623A3 (en) | Double-based low pressure discharge lamp. | |
ES1026166Y (es) | Baliza de señalizacion perfeccionada. | |
ITTO920282A0 (it) | Composizione polimerica amidacea biodegradabile. | |
ES1030717Y (es) | Baliza de señalizacion. | |
ES1029889Y (es) | Baliza aerostatica perfeccionada. | |
FI973408A (fi) | Siirrettävällä pohjalla varustettu säiliö | |
ITBO950012U1 (it) | Cerotto s.d. punto | |
NL1003251A1 (nl) | Slagvaste, transparante polymeersamenstelling en werkwijze voor de bereiding hiervan. | |
ES1025547Y (es) | Lampara polimerizadora. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 792288 Country of ref document: ES |